The State Food and Drug Administration (SFDA) issued the No.85 Drug Administrative Protection Announcement on April 27, 2006, declaring the ending of drug administrative protection for Pfizer 's Trovan tablets (trovafloxacin mesylate).

The State Food and Drug Administration (SFDA) issued the No.86 Drug Administrative Protection Announcement on April 29, 2006, declaring the ending of drug administrative protection for Mitsubishi Chemical Corporation 's Anplag (sarpogrelate hydrochloride).

The State Food and Drug Administration (SFDA) issued the No.87 Drug Administrative Protection Announcement on April 29, 2006, declaring the ending of drug administrative protection for Pfizer 's Trovan injection (alatrofloxacin mesylate).